Mandatum Life Insurance Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$278K Hold
232
– – 0.05% 73
2026
Q1
$213K Hold
232
– – 0.05% 76
2025
Q4
$249K Buy
+232
New +$222K 0.06% 65
2025
Q3
– Sell
-436
Closed -$340K – 89
2025
Q2
$340K Hold
436
– – 0.09% 63
2025
Q1
$360K Buy
436
+110
+34% +$91.5K 0.11% 63
2024
Q4
$252K Buy
326
+38
+13% +$31.5K 0.07% 73
2024
Q3
$255K Hold
288
– – 0.08% 70
2024
Q2
$261K Buy
+288
New +$230K 0.09% 68

Other funds holding LLY

Mandatum Life Insurance Company's LLY Position: Q2 2026 in Review

Mandatum Life Insurance Company held its Eli Lilly (LLY) position steady in Q2 2026 at 232 shares worth $278K. The position accounts for 0.05% of the portfolio, ranked #73.

Mandatum Life Insurance Company first reported a position in LLY in Q2 2024 and has held it in 8 quarters since. The position peaked at $360K in Q1 2025. 4,647 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Mandatum Life Insurance Company held 232 shares of Eli Lilly worth $278K as of Q2 2026.
  • Mandatum Life Insurance Company left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.05% of Mandatum Life Insurance Company's portfolio in Q2 2026, its #73 holding.
  • Mandatum Life Insurance Company first reported a position in Eli Lilly in Q2 2024 and has held it in 8 quarters since.
  • Mandatum Life Insurance Company's Eli Lilly position peaked at $360K in Q1 2025.
  • 4,647 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Mandatum Life Insurance Company's 13F filing for Q2 2026, filed 3 Aug 2026.